ClinicalTrials.Veeva

Menu

Validation of Receptor Occupancy Simulation

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Medication Satisfaction
Schizophrenia
Dopamine Receptor Occupancy
Prolactin Level

Study type

Observational

Funder types

Other

Identifiers

NCT01660880
A070001 (Other Grant/Funding Number)
C-1205-094-410

Details and patient eligibility

About

  • To estimate dopamine receptor occupancy by aripiprazole using computer simulation
  • To measure dopamine receptor occupancy by aripiprazole in patients treated with the antipsychotics
  • To validate the simulation result by comparing the receptor occupancy from the simulation with that from the patients

Enrollment

7 patients

Sex

All

Ages

20 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of schizophrenia
  • treated with aripiprazole or risperidone
  • no change in dose of antipsychotics for at least 6 weeks
  • total PANSS score should be below 80

Exclusion criteria

  • Other psychiatric disorders rather than schizophrenia
  • history of head trauma
  • positive in urine hCG
  • on antidepressant, anticholinergics or mood stabilizer

Trial design

7 participants in 1 patient group

aripiprazole
Description:
Patient group who is treated with aripiprazole

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems